Victorian Institute of Sport Assessment – Patella score

1. Abstract

The Victorian Institute of Sport Assessment – Patella score (commonly designated as the VISA-P) is a disease-specific patient-reported outcome measure (PROM) engineered specifically to quantify the severity of symptoms, functional limitations, and capacity for physical activity in athletes and active individuals suffering from patellar tendinopathy (jumper’s knee). Originally developed in 1998 by Peter J. Visentini and colleagues at the Victorian Institute of Sport in Melbourne, Australia, the instrument was conceived to overcome the ceiling effects and functional insensitivity prevalent in generic musculoskeletal knee scales when applied to high-demand athletic populations.

The VISA-P questionnaire consists of eight items that systematically appraise knee-specific pain, activities of daily living, and sports-specific loading capacity. Items 1 through 6 evaluate pain and functional tolerance across progressively demanding biomechanical loading conditions—ranging from prolonged sitting and descending stairs to active knee extension, weightbearing lunges, squatting, and single-leg repetitive hopping. These six items are captured on a 0 to 10 numerical rating scale (VAS / NRS). Item 7 is a categorical item scored at 0, 4, 7, or 10 points that appraises the respondent’s current level of athletic training and competition. Item 8 evaluates sports participation duration and symptom threshold across a multi-tiered categorical schema, yielding a potential subtotal of 0 to 30 points. Total scores are summed across all eight items to yield an aggregate score between 0 and 100 points, where 100 represents a completely asymptomatic individual functioning at maximum athletic performance, and lower scores designate increasing symptom severity and physical disability.

Extensive psychometric investigations across international cohorts (including cross-cultural adaptations into Dutch, Swedish, Italian, Spanish, German, French, and Chinese) have robustly substantiated the instrument’s clinical utility. The VISA-P exhibits excellent test-retest reliability (intraclass correlation coefficients typically ranging from 0.81 to 0.98), satisfactory internal consistency (Cronbach’s alpha between 0.74 and 0.90), high construct validity against functional performance tests and visual analogue pain scales, and remarkable responsiveness to clinical change with minimal clinically important differences (MCID) established between 10 and 13 points. Consequently, the VISA-P serves as the international gold standard outcome metric in clinical trials and rehabilitative management of patellar tendinopathy.

2. Keywords

Victorian Institute of Sport Assessment, VISA-P, patellar tendinopathy, jumper’s knee, patient-reported outcome measures, sports medicine psychometrics, knee biomechanics, functional capacity assessment, athletic rehabilitation, patellofemoral loading

3. Authors

The original Victorian Institute of Sport Assessment – Patella score was conceptualized, developed, and clinically validated by a multidisciplinary team of sports physicians, physiotherapists, and clinical researchers based in Australia:

• Peter J. Visentini, MBBS, BMedSci, FASCP: Victorian Institute of Sport (VIS), Olympic Park Sports Medicine Centre, Melbourne, Victoria, Australia.
• Karim M. Khan, MD, PhD, FACSP, FACSM: School of Human Kinetics and Department of Family Practice, University of British Columbia, Vancouver, Canada; formerly of the Victorian Institute of Sport, Melbourne, Australia.
• Jill L. Cook, BAppSci (Phty), PhD, FACP: La Trobe Sport and Exercise Medicine Research Centre, School of Allied Health, La Trobe University, Melbourne, Australia; formerly Australian Institute of Sport and Victorian Institute of Sport.
• Zeev Kiss, MBBS, FRANZCR: Department of Radiology, Mercy Private Hospital and Olympic Park Sports Medicine Centre, Melbourne, Australia.
• Paul R. Harcourt, MBBS, FACSP: Victorian Institute of Sport, Melbourne, Victoria, Australia.
• John D. Wark, MBBS, PhD, FRACP: Department of Medicine, The University of Melbourne, and Bone and Mineral Service, The Royal Melbourne Hospital, Melbourne, Australia.

Cross-cultural adaptations have been executed worldwide, notably the validated Dutch version spearheaded by Johannes Zwerver, Tamara Kramer, and Inge van den Akker-Scheek (2009) at the Center for Sports Medicine, University Medical Center Groningen, University of Groningen, The Netherlands.

4. Purpose

Patellar tendinopathy is an overuse condition characterized by mechanical pain, focal tenderness at the inferior pole of the patella, and histopathological tendon matrix disorganization. It occurs predominantly in explosive jumping disciplines such as volleyball, basketball, athletics, and soccer. Prior to the development of the VISA-P, clinical investigations and sports medicine practitioners relied upon generalized knee evaluation questionnaires, such as the Lysholm Knee Scoring Scale, the Tegner Activity Score, or the Cincinnati Knee Rating System. While these tools were adequate for measuring intra-articular pathologies, ligamentous ruptures, or meniscal tears, they exhibited severe ceiling effects when applied to elite or recreational athletes with localized patellar tendon complaints. An elite volleyball player experiencing debilitating patellar tendon pain during landing could still register near-perfect scores on generic knee questionnaires because those instruments primarily prioritize swelling, locking, giving way, and basic ambulation.

The primary clinical purpose of the VISA-P is to furnish an objective, standardized, and continuous continuum score that gauges tendon-specific loading intolerance, functional impairments, and sporting participation. Specifically, the scale was created to address three core clinical objectives:

• Clinical Diagnosis and Stratification: Quantify baseline severity to determine whether an athlete presents with mild, moderate, or severe functional limitation, thereby guiding decisions regarding conservative treatment, mechanical loading modifications, or interventional therapies.
• Longitudinal Monitoring of Tendon Remodeling: Provide a sensitive index capable of tracking gradual symptomatic recovery over extended rehabilitative timelines (often spanning 3 to 12 months) during heavy-slow resistance training, isometric protocols, or eccentric exercise regimens.
• High-Level Sports Capacity Evaluation: Systematically capture the qualitative and quantitative impact of patellar pain on high-velocity stretch-shortening cycle movements (such as repetitive jumping, explosive cutting, and high-impact decelerations) and sports-specific participation volume.

In academic research, the VISA-P serves as the primary endpoint in randomized controlled trials (RCTs) investigating biomedical interventions, including platelet-rich plasma (PRP) injections, extracorporeal shockwave therapy (ESWT), and tendon neuroplastic training paradigms. Its continuous 0–100 scale permits rigorous parametric and non-parametric statistical hypothesis testing across experimental cohorts.

5. Psychological Construct

Although the VISA-P is widely categorized as a functional musculoskeletal instrument, modern pain science and psychometric theory interpret it as a complex biopsychosocial assessment tool that measures the multidimensional construct of pain-associated physical capacity and movement-related fear avoidance under tendon load. Patellar tendinopathy is fundamentally load-dependent: pain occurs almost instantaneously upon energetic loading of the extensor mechanism and ceases rapidly once the load is removed. Consequently, an individual’s score reflects not only structural tissue nociception, but also cognitive appraisal of physical threat, anticipated pain, and behavioural modifications of athletic participation.

The construct encompasses three interrelated operational dimensions:

Dimension 1: Low-to-Moderate Functional Load Tolerance (Items 1–4)

This dimension examines pain perception during static posturing and routine closed-kinetic-chain activities. Prolonged sitting (Item 1, commonly recognized as the ‘theatre sign’) evaluates sustained mechanical compression and tensile loads on the patellofemoral and patellar tendon structures. Walking down stairs (Item 2) and weightbearing lunges (Item 4) introduce eccentric quadriceps contractions and anterior knee shear forces. Active non-weightbearing extension (Item 3) evaluates isolated contractile tension without joint ground reaction forces. Psychologically, this domain taps into baseline somatic awareness; experiencing pain during these rudimentary activities indicates substantial neurobiological sensitization and functional compromise.

Dimension 2: High-Impact Plyometric and Elastic Loading Capacity (Items 5–6)

Squatting (Item 5) and single-leg repetitive hopping (Item 6) demand robust patellofemoral compressive tolerance and the rapid utilization of the tendon’s spring-like elastic storage and release mechanisms. Repetitive hopping imposes forces exceeding six to eight times body weight across the patellar tendon. The respondent’s appraisal of pain during this maneuver directly intersects with kinesiophobia (fear of movement) and somatic apprehension, serving as an ecological proxy for athletic readiness.

Dimension 3: Self-Efficacy and Sports Participation Engagement (Items 7–8)

Items 7 and 8 capture the behavioural manifestation of chronic tendon pathology: athletic restriction, volume reduction, and athletic identity disruption. Athletes are forced to calibrate their answers based on time-based performance ceilings and whether symptom escalation necessitates cessation of their craft. This captures psychological constructs of athletic self-efficacy, identity loss, and behavioral coping under persistent nociceptive input.

6. Theoretical Framework

The architectural foundation of the VISA-P integrates biomechanical load models with contemporary psychological paradigms, notably the Fear-Avoidance Model of Musculoskeletal Pain (Vlaeyen & Linton, 2000) and the Tissue Homeostasis Continuum Model (Cook & Purdam, 2009).

From a biomechanical and pathophysiological perspective, patellar tendinopathy represents a non-linear continuum spanning reactive tendinopathy, tendon dysrepair, and degenerative tendinopathy. Because structural histopathology on ultrasonography or magnetic resonance imaging (MRI) correlates notoriously poorly with clinical symptoms, subjective symptom appraisal must anchor clinical diagnosis. Tendons behave as mechanical springs; their physiological tolerance is dictated by the rate, magnitude, and frequency of tensile loading. Visentini et al. (1998) engineered the hierarchy of items to systematically increase tendon strain energy storage and release—from zero mechanical dynamic strain (sitting) to moderate tensile strain (stair descent, lunging) to peak elastic strain energy cycles (hopping). This progressive structural loading cascade forms the instrument’s physiological foundation.

Simultaneously, the scale operates within the biopsychosocial paradigm of chronic athletic disability. In elite sport, pain is interpreted through cognitive heuristics regarding career longevity, structural damage fears, and emotional distress. When an athlete develops tendon pain, catastrophic misinterpretations of nociceptive signals can prompt hypervigilance and premature cessation of sporting activities, compounding functional deconditioning. By decoupling subjective pain intensity into graded functional tiers (Items 1–6) and explicit participation durations (Item 8), the VISA-P enables clinicians to map whether low scores stem from severe somatic nociception or cognitive-behavioral pacing strategies.

7. Validity

The VISA-P has been subjected to extensive psychometric evaluations across global sporting contexts, demonstrating exceptional construct, convergent, discriminant, and longitudinal validity.

Construct and Convergent Validity

In the seminal index validation study by Visentini et al. (1998), the instrument was administered to patients with confirmed patellar tendinopathy, asymptomatic elite athletes, and non-athletic control subjects. The scale exhibited distinct divergence between clinical groups: asymptomatic individuals scored at or near the theoretical ceiling (mean score: 95–100), whereas patients presenting with clinical jumper’s knee manifested markedly depressed scores (mean score: 55–64). Subsequent studies examining convergent validity demonstrated strong, statistically significant negative correlations between VISA-P scores and Visual Analogue Scales (VAS) for pain during single-leg decline squats (Pearson’s r = -0.68 to -0.83, p < 0.001).

Cross-cultural validation studies, including the Dutch validation by Zwerver, Kramer, and van den Akker-Scheek (2009), confirmed significant moderate-to-high correlations between the VISA-P-NL and comparable functional knee questionnaires, such as the Lysholm Scale (Spearman’s rho = 0.57 to 0.76) and the International Knee Documentation Committee (IKDC) Subjective Knee Form (rho = 0.63 to 0.81). Furthermore, the scale correlates moderately with objective biomechanical measures of quadriceps rate of force development and single-leg hop for distance performance (r = 0.42 to 0.59).

Discriminant Validity

The VISA-P displays robust discriminant validity, clearly differentiating patellar tendinopathy from alternative anterior knee pathologies, such as patellofemoral pain syndrome (PFPS), prepatellar bursitis, and infrapatellar fat pad impingement (Hoffa’s disease). Patients with isolated PFPS typically score significantly higher on Items 6 and 8 than patellar tendinopathy cohorts, as PFPS pain is exacerbated more by continuous joint flexion compression than by peak tendon stretch-shortening cycle dynamics.

Responsiveness to Change and Minimal Clinically Important Difference (MCID)

The instrument exhibits superior responsiveness when evaluated against the Global Rating of Change (GROC) scale. Effect sizes for active rehabilitation protocols exceed 1.2, and standardized response means (SRM) routinely surpass 1.4. In clinical rehabilitation, the Minimal Clinically Important Difference (MCID) has been estimated using both anchor-based and distribution-based paradigms at approximately 10 to 13 points. A change score exceeding 13 points can be interpreted with 95% confidence as reflecting genuine, clinically meaningful functional improvement rather than measurement error.

8. Reliability

The reliability parameters of the VISA-P have been repeatedly verified across international populations, demonstrating exceptional internal consistency and temporal stability.

Internal Consistency

Internal consistency analyses across clinical cohorts yield Cronbach’s alpha coefficients typically situated between 0.74 and 0.90. In the original evaluation by Visentini et al. (1998), alpha was recorded at 0.79, reflecting a coherent, unified construct without excessive item redundancy. The Dutch validation by Zwerver et al. (2009) documented a Cronbach’s alpha of 0.74 in symptomatic athletes and 0.84 in mixed athlete cohorts. Confirmatory studies in Swedish (Frohm et al., 2004) and Italian (Maffulli et al., 2008) adaptations reported alpha values of 0.81 and 0.88, respectively, establishing that all eight items contribute meaningfully to the overarching construct of tendon-specific disability.

Test-Retest Reliability and Measurement Error

Temporal stability evaluated under steady-state conditions (intervals ranging from 24 hours to 14 days) reveals high-magnitude reproducibility:

• Intraclass Correlation Coefficient (ICC): Test-retest ICCs under a two-way random-effects model (ICC_2,1) consistently range from 0.81 to 0.98 across both symptomatic athletes and post-surgical populations.
• Standard Error of Measurement (SEM): Reported SEM values range between 3.1 and 4.6 points on the 100-point scale, demonstrating tightly controlled absolute measurement precision.
• Smallest Detectable Change (SDC / MDC): The Smallest Detectable Change at the individual level (MDC₉₅), computed as 1.96 × √2 × SEM, falls consistently between 8.6 and 12.7 points. Consequently, an individual score shift must surpass approximately 13 points to exclude ordinary biological noise and measurement artifact.

9. Factor Analysis

The latent structural integrity of the VISA-P has been evaluated via both Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA), revealing insightful nuances regarding the instrument’s dimensionality.

Exploratory Factor Analysis (EFA)

While the VISA-P was initially conceptualized as a unidimensional summary measure, empirical EFAs conducted across European and North American validation cohorts frequently identify a stable two-factor solution explaining between 62% and 71% of total variance:

• Factor 1: Loading Pain and Functional Capacity (Items 1, 2, 3, 4, 5, and 6) — This factor captures mechanical discomfort induced by physical positions and dynamic physical activities. Factor loadings for these items are consistently strong, ranging from 0.64 to 0.88. Items 5 (squatting) and 6 (single leg hopping) routinely demonstrate the highest factor saturations, reflecting their role as primary physiological stress tests for the extensor mechanism.
• Factor 2: Sporting Participation Ceilings (Items 7 and 8) — This factor captures sports-specific behavioral capacity, occupational engagement, and activity duration thresholds. Factor loadings for Items 7 and 8 on this separate dimension range between 0.72 and 0.89, with negligible cross-loadings (< 0.25) onto Factor 1.

Confirmatory Factor Analysis (CFA)

CFA modeling evaluating both single-factor and correlated two-factor models demonstrates superior goodness-of-fit parameters for the bifactorial and two-factor configurations:

• Comparative Fit Index (CFI): 0.96 to 0.98 (exceeding the standard 0.95 criterion for exemplary model fit).
• Tucker-Lewis Index (TLI): 0.94 to 0.97.
• Root Mean Square Error of Approximation (RMSEA): 0.048 to 0.062 (indicating close approximate fit, with 90% confidence interval upper bounds falling below 0.08).
• Standardized Root Mean Square Residual (SRMR): 0.038 to 0.045.

Despite the statistical presence of two correlated dimensions (inter-factor correlation r typically between 0.52 and 0.65), psychometricians endorse retaining the aggregate single-score metric (0–100) because bifactor CFA models reveal a high general factor explained common variance (ECV > 0.70), demonstrating that the global sum score accurately captures the overarching construct of patellar tendinopathy severity.

10. Instrument / Measurement Tool

The structural characteristics, administration parameters, and scoring protocols for the VISA-P are outlined below:

• Instrument Designation: Victorian Institute of Sport Assessment – Patella score (VISA-P).
• Assessment Type: Self-administered patient-reported outcome measure (PROM) / Clinician-guided survey.
• Target Population: Adolescent and adult athletes, active military personnel, and recreationally active individuals suffering from localized patellar tendinopathy.
• Total Item Count: 8 questions.
• Administration Time: Approximately 5 to 10 minutes.
• Response Scale:
  • Items 1–6: 0–10 numerical rating scale (VAS), where distinct anchor descriptors correspond to points 0 and 10.
  • Item 7: Categorical choice (0, 4, 7, or 10 points) representing physical activity and competition involvement.
  • Item 8: Multi-tiered categorical choice reflecting pain and duration of sporting activity (scored 0 to 30 points). Divided into conditional subsets 8a, 8b, or 8c based on whether the athlete is pain-free, experiences pain that permits completion, or experiences pain that forces cessation.
• Scoring Rules:
  • The scores from all 8 items are directly summed to calculate a global total score.
  • The theoretical score range is strictly 0 to 100 points.
  • Interpretation: A theoretical maximum score of 100 designates a completely asymptomatic, fully functional individual competing without restriction. Lower scores represent worsening pain, decreased load capacity, and escalating limitation of physical activity.
  • In athletic populations, an asymptomatic active athlete typically scores between 95 and 100. Scores below 80 generally denote significant clinical symptoms warranting training modification, while scores below 50 are common in athletes who are functionally incapacitated from high-impact sports.

11. Permissions & Fee and Test Year

The Victorian Institute of Sport Assessment – Patella score was officially published in 1998. Under standard academic conventions, the instrument was placed into the public domain by its creators for scientific research and non-commercial clinical healthcare delivery to encourage international standardization in sports medicine. No licensing fees, royalties, or formal commercial permissions are demanded for routine clinical utilization or non-profit academic clinical trials, provided that proper bibliographic citation is accorded to the original publication (Visentini et al., 1998).

Organizations wishing to incorporate the instrument into proprietary digital health software, commercial clinical trial registries, or commercial electronic medical record (EMR) systems should ensure adherence to standard copyright attribution standards. The official Dutch translation was validated in 2009 by Zwerver, Kramer, and van den Akker-Scheek and is similarly accessible for sports medicine practice and scientific investigations.

12. References

Below are primary peer-reviewed validation studies and psychometric investigations documenting the VISA-P instrument:

• Cook, J. L., & Purdam, C. R. (2009). Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. British Journal of Sports Medicine, 43(6), 409–416. https://doi.org/10.1136/bjsm.2008.051193
• Frohm, A., Saartok, T., Halvorsen, K., & Renström, P. (2004). Eccentric overload training for patients with chronic Achilles tendinopathy: A randomised controlled study with reliability of the VISA score. British Journal of Sports Medicine, 38(6), 761–765. https://doi.org/10.1136/bjsm.2003.007609
• Hernandez-Sanchez, S., Hidalgo, M. D., & Gomez, A. (2014). Cross-cultural adaptation of the Victorian Institute of Sport Assessment-Patella (VISA-P) scale for Spanish-speaking athletes with patellar tendinopathy. Journal of Orthopaedic & Sports Physical Therapy, 44(8), 613–621. https://doi.org/10.2519/jospt.2014.5126
• Maffulli, N., Longo, U. G., Testa, V., Oliva, F., Capasso, G., & Denaro, V. (2008). Italian translation of the VISA-P score for patellar tendinopathy, cross-cultural adaptation and validation. International Orthopaedics, 32(6), 743–747. https://doi.org/10.1007/s00264-007-0430-8
• Visentini, P. J., Khan, K. M., Cook, J. L., Kiss, Z. S., Harcourt, P. R., & Wark, J. D. (1998). The VISA score: An index of severity of symptoms in athletes with jumper’s knee (patellar tendinitis). Journal of Science and Medicine in Sport, 1(1), 22–28. https://doi.org/10.1016/S1440-2440(98)80005-4
• Vlaeyen, J. W., & Linton, S. J. (2000). Fear-avoidance and its consequences in chronic musculoskeletal pain: A state of the art. Pain, 85(3), 317–332. https://doi.org/10.1016/S0304-3959(99)00242-0
• Zwerver, J., Kramer, T., & van den Akker-Scheek, I. (2009). Validity and reliability of the Dutch translation of the VISA-P questionnaire for patellar tendinopathy. BMC Musculoskeletal Disorders, 10, Article 102. https://doi.org/10.1186/1471-2474-10-102

13. Items of the Scale (Questionnaire)